Vânia André

Dr. Vânia André

Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2007 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
PGPedro M. P. Gois
Pedro M. P. Gois
ATAlexandre F. Trindade
Alexandre F. Trindade
LVLuís Filipe Veiros
Luís Filipe Veiros
Vânia AndréVânia André
Vânia André
MDMaria Teresa Duarte
Maria Teresa Duarte
FCF. Geoffrey N. Cloke
F. Geoffrey N. Cloke

7 July 2011 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Vânia AndréVânia André
Vânia André
AHAndrew Hardeman
Andrew Hardeman
IHIvan Halasz
Ivan Halasz
RSRobin S. Stein
Robin S. Stein
GJGraham J. Jackson
Graham J. Jackson
TFTomislav Friščić
Tomislav Friščić

3 February 2015 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
SDSofia Domingos
Sofia Domingos
Vânia AndréVânia André
Vânia André
SQSílvia Quaresma
Sílvia Quaresma
Inês C. B. MartinsInês C. B. Martins
Inês C. B. Martins
MPManuel E. Minas da Piedade
Manuel E. Minas da Piedade
MDMaria Teresa Duarte
Maria Teresa Duarte
Objectives: In a short approach, we want to present the improvements that have recently been done in the world of new solid forms of known active pharmaceutical ingredients (APIs). The different strategies will be addressed, and successful examples will be given. Key findings: This overview presents a possible step to overcome the 10–15 years of hard work involved in launching a new drug in the market: the use of new forms of well-known APIs, and improve their efficiency by enhancing their bioavailability and pharmacokinetics. It discusses some of the latest progresses. Summary: We want to present, in a brief overview, what recently has been done to improve the discovery of innovative methods of using well-known APIs, and improve their efficiency. Multicomponent crystal forms have shown to be the most promising achievements to accomplish these aims, by altering API physico-chemical properties, such as solubility, thermal stability, shelf life, dissolution rate and compressibility. API-ionic liquids (ILs) and their advantages will be briefly referred. An outline of what has recently been achieved in metal drug coordination and in drug storage and delivery using bio-inspired metal-organic frameworks (BioMOFs) will also be addressed.

6 May 2008 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
ATAlexandre F. Trindade
Alexandre F. Trindade
PGPedro M. P. Gois
Pedro M. P. Gois
LVLuís Filipe Veiros
Luís Filipe Veiros
Vânia AndréVânia André
Vânia André
MDMaria Teresa Duarte
Maria Teresa Duarte
FCF. Geoffrey N. Cloke
F. Geoffrey N. Cloke

1 April 2010 in Tetrahedron
Verified
Journal Article
Closed access
NCNuno Candeias
Nuno Candeias
PCPedro M.S.D. Cal
Pedro M.S.D. Cal
Vânia AndréVânia André
Vânia André
MDMaria Teresa Duarte
Maria Teresa Duarte
LVLuís Filipe Veiros
Luís Filipe Veiros
PGPedro M. P. Gois
Pedro M. P. Gois